Additionally, mPEG-PLGA-PLL nanoparticles successfully deliver epidermal growth factor (EGF) and Bcl-2-siRNA genes to target H1299 lung cancer cells, resulting in inhibited tumor growth by reducing Bcl-2 expression in tumor tissues. This evidence concerns the gene BCL2 and neoplasm.